Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Sneddon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Chemical Biology|May 29, 2021
Emerging chelators for nuclear imagingDeborah Sneddon, Bart Cornelissen
Journal of Enzyme Inhibition and Medicinal Chemistry|February 11, 2014
Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expressionDeborah Sneddon, Sally-Ann Poulsen
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2021
A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear EpitopesMathew Veal, Gemma Dias, Veerle Kersemans, et al.
Chemmedchem|July 14, 2021
Zap-Pano: a Photocaged Prodrug of the KDAC Inhibitor PanobinostatKathrin S Troelsen, Ewen D D Calder, Anna Skwarska, et al.
Cell Chemical Biology|April 28, 2021
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitorAnna Skwarska, Ewen D D Calder, Deborah Sneddon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECTHudson Alakonya, Sofia Koustoulidou, Samantha L Hopkins, et al.
Inorganic Chemistry|March 24, 2025
LnDOTA Releasing Probes for Luminescence and Magnetic Resonance ImagingCeri A Foster, Deborah Sneddon, Lina Hacker, et al.
Journal of Medicinal Chemistry|June 21, 2016
Synthesis and in Vivo Biological Evaluation of (68)Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission TomographyDeborah Sneddon, Raymon Niemans, Matthias Bauwens, et al.
EMBO Molecular Medicine|July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Chemical Biology|May 29, 2021
Emerging chelators for nuclear imagingDeborah Sneddon, Bart Cornelissen
Journal of Enzyme Inhibition and Medicinal Chemistry|February 11, 2014
Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expressionDeborah Sneddon, Sally-Ann Poulsen
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2021
A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear EpitopesMathew Veal, Gemma Dias, Veerle Kersemans, et al.
Chemmedchem|July 14, 2021
Zap-Pano: a Photocaged Prodrug of the KDAC Inhibitor PanobinostatKathrin S Troelsen, Ewen D D Calder, Anna Skwarska, et al.
Cell Chemical Biology|April 28, 2021
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitorAnna Skwarska, Ewen D D Calder, Deborah Sneddon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECTHudson Alakonya, Sofia Koustoulidou, Samantha L Hopkins, et al.
Inorganic Chemistry|March 24, 2025
LnDOTA Releasing Probes for Luminescence and Magnetic Resonance ImagingCeri A Foster, Deborah Sneddon, Lina Hacker, et al.
Journal of Medicinal Chemistry|June 21, 2016
Synthesis and in Vivo Biological Evaluation of (68)Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission TomographyDeborah Sneddon, Raymon Niemans, Matthias Bauwens, et al.
EMBO Molecular Medicine|July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Pageof 1